Sponsor Collaborators Module
The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.
Sponsor Collaborators Module path is as follows:
Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators
Sponsor Collaborators Module
Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-25 @ 1:50 PM
NCT ID:
NCT04781192
Responsible Party Type:
SPONSOR
Study:
NCT04781192
Study Brief:
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
Protocol Section:
NCT04781192
Collaborators (If Any):